Warning: The NCBI web site requires JavaScript to function. more...
The Chinese government's response to drug use and HIV/AIDS: a review of policies and programs.
Li J, Ha TH, Zhang C, Liu H.
Harm Reduct J. 2010 Mar 5;7:4.
Related citations
Drug use and HIV/AIDS in China.
Liu Z, Lian Z, Zhao C.
Drug Alcohol Rev. 2006 Mar;25(2):173-5. Review.
Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implications.
Qian HZ, Schumacher JE, Chen HT, Ruan YH.
Harm Reduct J. 2006 Feb 1;3:4.
'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
Hammett TM, Wu Z, Duc TT, Stephens D, Sullivan S, Liu W, Chen Y, Ngu D, Des Jarlais DC.
Addiction. 2008 Jan;103(1):137-45. Epub 2007 Nov 20. Review.
Advocacy for harm reduction in China: a new era dawns.
Reid G, Aitken C.
Int J Drug Policy. 2009 Jul;20(4):365-70. Epub 2008 Dec 20.
Harm reduction for injecting opiate users: an update and implications in China.
Meise M, Wang X, Sauter ML, Bao YP, Shi J, Liu ZM, Lu L.
Acta Pharmacol Sin. 2009 May;30(5):513-21. Epub 2009 Apr 6. Review.
Harm reduction: Australia as a case study.
Wodak A.
Bull N Y Acad Med. 1995 Winter;72(2):339-47.
HIV infection among intravenous drug users: epidemiology and risk reduction.
Des Jarlais DC, Friedman SR.
AIDS. 1987 Jul;1(2):67-76. Review.
Rapid scale up of harm reduction in China.
Sullivan SG, Wu Z.
Int J Drug Policy. 2007 Mar;18(2):118-28. Epub 2007 Feb 14. Review.
[Drug addiction: harm reduction policies in France and Spain].
Ramirez-Jonville A.
Presse Med. 2006 Jul-Aug;35(7-8):1151-61. French.
Consequences of drug abuse and HIV/AIDS in China: recommendations for integrated care of HIV-infected drug users.
Li X, He G, Wang H, Williams AB.
AIDS Patient Care STDS. 2009 Oct;23(10):877-84. Review.
Psychoeducational group approach: HIV risk reduction in drug users.
Sorensen JL, London J, Heitzmann C, Gibson DR, Morales ES, Dumontet R, Acree M.
AIDS Educ Prev. 1994 Apr;6(2):95-112.
Health and human rights concerns of drug users in detention in Guangxi Province, China.
Cohen JE, Amon JJ.
PLoS Med. 2008 Dec 9;5(12):e234.
The Association of Nurses in AIDS Care. Position paper on harm reduction and HIV care for drug users: integrating harm-reduction methods and HIV care.
Fisk SN.
J Assoc Nurses AIDS Care. 1998 May-Jun;9(3):19-24.
Ban on needle swaps blamed for 10,000 U.S. infections.
[No authors listed]
AIDS Policy Law. 1996 Jul 26;11(13):3.
The role of harm reduction in controlling HIV among injecting drug users.
Wodak A, McLeod L.
AIDS. 2008 Aug;22 Suppl 2:S81-92.
Advocacy and coverage of needle exchange programs: results of a comparative study of harm reduction programs in Brazil, Bangladesh, Belarus, Ukraine, Russian Federation, and China.
Burrows D.
Cad Saude Publica. 2006 Apr;22(4):871-9. Epub 2006 Apr 5.
HIV risk behaviors but absence of infection among drug users in detoxification centers outside Yunnan province, China, 1993.
Zheng X, Tian C, Zhang G, Li D, Liu X, Hu DJ, Weniger BG, Dondero TJ.
AIDS. 1995 Aug;9(8):959-63.
Accelerating harm reduction interventions to confront the HIV epidemic in the Western Pacific and Asia: the role of WHO (WPRO).
Mesquita F, Jacka D, Ricard D, Shaw G, Tieru H, Hu Y, Poundstone K, Salva M, Fujita M, Singh N.
Harm Reduct J. 2008 Aug 5;5:26.
Impact of HIV prevention programs on drug users in Malaysia.
Kamarulzaman A.
J Acquir Immune Defic Syndr. 2009 Nov;52 Suppl 1:S17-9. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on